Berotralstat Treatment in Children With Hereditary Angioedema
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Hereditary Angioedema
Related studies linked through entity extraction aliases.
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2/PHASE3
A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)
- Status
- COMPLETED
- Phase
- PHASE3
A Single and Multiple Doses Safety, Tolerability, Pharmacokinetics and Food Effect Study of KVD824 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE)
- Status
- COMPLETED
- Phase
- PHASE3
A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
NTLA-2002 in Adults With Hereditary Angioedema (HAE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase 1 Crossover Study in Healthy Subjects to Evaluate the PK Profile of KVD824 Following Single and Multiple Doses of Modified Release (MR) Formulations
- Status
- COMPLETED
- Phase
- PHASE1
Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Burden of Illness and Treatment Patterns in Teenagers and Adults With Hereditary Angioedema
- Status
- COMPLETED
- Phase
- N/A
Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Assessment of the State of Health, Quality of Life and Expectations of Patients With Hereditary Angioedema
- Status
- COMPLETED
- Phase
- N/A
Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks
- Status
- COMPLETED
- Phase
- PHASE3
Expanded Access Program With Lanadelumab for Japanese People With Hereditary Angioedema
- Status
- COMPLETED
- Phase
- PHASE3
CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema
- Status
- COMPLETED
- Phase
- PHASE3
Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Pharmacokinetics of GNR-038 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1